A few points for the naysayers to consider:
1. Why the strong fixation on PE only? Looking at one metric in isolation is a fairly imbalanced assessment of the company. Also, PEG is generally a more useful metric for high growth companies.
2. In a market downturn, low growth rates don't necessarily apply to the same extent across all companies. Companies that can offer cost saving solutions (ie. AI to improve/accelerate MRI diagnostics) will have a reasonable chance at maintaining high growth levels. Also, hospitals will still need to conduct MRIs in a downturn.
3. Why would directors and PME themselves buy shares at higher levels than present, if the growth was suddenly going to dissipate and turn anemic?
Long term, this is a sound and profitable business with low overheads and a scalable product. Positive momentum will eventually return.
A few points for the naysayers to consider:1. Why the strong...
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$113.52 |
Change
1.420(1.27%) |
Mkt cap ! $11.85B | |||
| Open | High | Low | Value | Volume |
| $112.10 | $113.93 | $112.06 | $16.17M | 142.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 144 | $113.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $113.67 | 328 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$113.59 |
Change
1.420 ( 1.11 %) |
||||
| Open | High | Low | Volume | ||
| $112.17 | $113.91 | $112.17 | 26535 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| PME (ASX) Chart |